The US spends twice the OECD per-capita average yet ranks last among wealthy nations in health outcomes. 32 million Americans have no coverage. Should one public payer replace private insurance entirely? Two debaters, opposing sides — you score who makes the stronger case.
Wednesday, September 2, 2026 · 7:00 PM EDT
What's at stake
If M4A works, 32 million Americans gain coverage and medical bankruptcies end. If it fails, a $30 trillion gamble dismantles a system 160 million people currently rely on.
The Matchup
Debater: To be announced
Debater: To be announced
Join the debate
Record a 60-second video on either side, or make it in writing. The strongest cases get featured before the live debate.
“I'm British and have lived in the US for 36 years, so I feel qualified to present the facts. No one in the UK has to worry about a medical bill or going to see a doctor. What no one tells you here in the US is that you can buy private insurance in the UK. It's not all or nothing. You pay into the system just like you pay into social security. I will retire back to the UK, as the last thing I want to worry about is medical bills. The system in the UK is not perfect. 99% of the people that are against single payer healthcare have never lived anywhere outside the US.”
“The US spent $4.5 trillion on healthcare in 2022 — more than $13,000 per person — yet 32 million remained uninsured. Administrative overhead alone consumes 34 cents of every private-insurance dollar; Canada's single-payer spends 12 cents. M4A's administrative savings alone could cover the uninsured.”
“Independent analyses estimate M4A at $30–40 trillion in new federal spending over ten years. Financing it requires roughly doubling federal income taxes or equivalent revenue — a political and economic constraint that no serious M4A proposal has resolved without painful tradeoffs.”
“The US produces 40% of the world's new drugs and medical devices, driven by the profit incentives of a competitive market. Single-payer systems in Europe and Canada routinely delay access to cutting-edge treatments that US patients get first. Eliminating private insurance removes the pricing signal that drives pharmaceutical R&D.”
The Format
Standard SuperDebate: two people, cross-examination, moderated from start to finish.
4 min · PRO · opening case
4 min · CON questions PRO
4 min · CON · opening case
4 min · PRO questions CON
3 min · PRO
3 min · CON
3 min · PRO · final case
3 min · CON · final case
— · You pick the winner
Don't miss it
The debate happens live with real-time audience voting. Get one email right before we go live, with the watch link.
Premieres
Wednesday, September 2, 2026 · 7:00 PM EDT
Open debate runs on the people who show up. Tell us how you want to be part of it.
Structured debates on the ideas that matter most. You score who makes the stronger case.
Humanity uses 1.7 Earths yearly. Degrowth economists say rich nations must shrink; others say technology can decouple growth from harm. Can the planet survive endless growth — or is degrowth a recipe for poverty? Two debaters, opposing sides — you score who makes the stronger case.
Aging kills 100,000 people every day — more than cancer and war combined. Google's Calico has invested billions in life-extension research. Should we treat aging as a disease — or accept it as part of a meaningful life? Two debaters, opposing sides — you score who makes the stronger case.
The US has spent over $1 trillion on the drug war since 1971 — overdoses still hit 107,000 in 2023. Portugal decriminalized all drugs in 2001 and saw deaths plummet. Does legalization fix it — or abandon the most vulnerable? Two debaters, opposing sides — you score who makes the stronger case.
South Korea's birth rate hit 0.72 in 2023 — a record low. Japan and Hungary pay tens of thousands per child; birthrates keep falling. Is population collapse a civilizational crisis — or a feature of modernity and freedom? Two debaters, opposing sides — you score who makes the stronger case.